Imunon
IMNN
15 hedge funds and large institutions have $403K invested in Imunon in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0% more ownership
Funds ownership: 0.34% → 0.34% (+0%)
6% less funds holding
Funds holding: 16 → 15 (-1)
22% less capital invested
Capital invested by funds: $515K → $403K (-$112K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.2K |
| 2 |
Renaissance Technologies
New York
|
+$13.1K |
| 3 |
JP Morgan Chase
New York
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$10.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.15K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$281 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$156 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$78 |
IMNN Hedge Fund Activity: Q3 2023 in Review
15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2023, worth a combined $403K — down 22% from $515K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IMNN and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $21.2K. The largest seller was BlackRock, cutting an estimated $10.3K.
- 15 institutional investors held Imunon (IMNN) as of Q3 2023, down from 16 in Q2 2023.
- Funds reported $403K of Imunon stock for Q3 2023, down 22% quarter-over-quarter.
- 1 fund opened new Imunon positions in Q3 2023 and 2 closed out, a net change of -1 holder.
- The largest Imunon buyer in Q3 2023 was Geode Capital Management, an estimated $21.2K added.
- The largest Imunon seller in Q3 2023 was BlackRock, an estimated $10.3K sold.
Based on aggregated 13F filings for Q3 2023.